Press Release

Legend Biotech Corporation Announces Pricing of Initial Public Offerin

2020-06-05

Legend Biotech IPO FAQ

2020-05-30

GenScript Biotech announces CE-IVD for its Neutralizing Antibody Test kit of SARS-CoV-2 and COVID-19 diagnostic products

2020-05-26

Duke-NUS, GenScript and A*STAR launch SARS-CoV-2 serology test

2020-05-15

GenScript Strives for Research Excellence Amidst the Global COVID-19 Pandemic | GenScript

2020-03-20

Legend Spinoff Discussion

2020-03-15

B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T Cell Therapy | GenScript

2019-11-07

Join Forces | GenScript Biotech & REMD Biotherapeutics Inc. Reached a Strategic Collaboration to Develop Several Bispecific Antibodies

2019-04-26

GenScript Launches Beta Testing Program for New Precision Mutant Library Services

2019-04-24

GenScript Launches Single-stranded DNA Service for CRISPR-based Gene Editing

2019-04-01

GenScript to Fund Generation of First Sustainable Drosophila Antibody Library

2019-03-28

Legend Biotech Presents Updated Phase 1/2 LCAR-B38M Data in Patients with Multiple Myeloma

2018-12-03

GenScript to launch new platform to save up to a billion USD for worldwide research community

2018-07-09

GenScript Investing $75 million in the New Biologics GMP Facility

2018-07-05

GenScript signs a strategic cooperative memorandum of understanding with the Innovation Center for Immune Therapy (ICIT) of Tsinghua University

2018-06-13

GenScript Supports the Development of a Novel HIV Vaccine

2018-06-12

Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple Myeloma

2018-05-30

Legend Biotech Announces Closing of Global Strategic LCAR-B38M Car-T Cell Immunotherapy Collaboration with Janssen

2017-12-22

GenScript Congratulates KLT Pharma on CFDA IND Approval

2017-10-25

GenScript Launches Custom Rabbit Monoclonal Antibody Service

2017-06-27